Roivant Sciences Ltd.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-552.1M | $-557.9M | $5.8M | $85.0M |
| FY2022 | $-677.7M | $-695.2M | $17.4M | $565.0M |
| FY2023 | $-843.4M | $-856.1M | $12.7M | $217.8M |
| FY2024 | $-765.3M | $-766.7M | $1.4M | $199.6M |
| FY2025 | $-839.5M | $-844.1M | $4.6M | $289.0M |
| FY2026 | $-750.3M | $-758.6M | $8.2M | $346.2M |